Clinical outcomes and quality of life after proton therapy for cranial and extracranial solitary fibrous tumors
BJR|Open · 18.01.2026 · 8 (1)
DOI: 10.1093/bjro/tzag023 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJR|Open, online erschienen am 26.10.2026. Verfasst von Philipp Reinhardt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Solitary fibrous tumors (SFTs) are rare malignancies. Surgical resection, particularly gross total resection, is the mainstay of therapy. The benefit of postoperative radiotherapy (RT) remains uncertain, with inconsistent findings across studies. Existing literature predominantly reported photon-based RT. This study evaluates clinical outcomes, late toxicities, and quality of life (QoL) in patients with SFTs treated with postoperative pencil beam scanning proton therapy (PT).
Methods
We performed a retrospective single-center analysis of patients with histologically confirmed cranial or extracranial SFTs treated with PT. Local control (LC) was assessed using Brain Tumor Reporting and Data System (BT-RADS) or Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Toxicities were recorded using Common Terminology Criteria for Adverse Events (CTCAE) v5.0, and QoL was assessed prospectively in patients with cranial SFTs. Kaplan-Meier analysis was used to estimate overall survival (OS) and LC, with subgroup comparisons made using the log-rank test.
Results
Seventeen patients were included, with a majority presenting with cranial SFTs (64.7%). After a median follow-up of 47 months (range 7-208 months), OS was 100%. The 5-year LC rate was 81.8% (95% CI, 61.9%-100%) for the entire cohort. Acute toxicities were limited to grade 1-2. Two patients (11.8%) experienced severe late toxicity. Overall QoL appeared broadly stable over time and was comparable to reference population values.
Conclusion
PT provided encouraging preliminary OS and LC rates in patients with cranial and extracranial SFTs. Despite a low rate, the severity of these late toxicities highlights substantial risks near the central nervous system axis. Advances in knowledge This retrospective single-center study provides the largest analyzed cohort of patients with cranial and extracranial SFTs treated with PT to our knowledge.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland.
- Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
ORCID-Profile: Philipp Reinhardt
Zitieren
APA
Reinhardt, P., Bolsi, A., & Weber, D. C. (2026). Clinical outcomes and quality of life after proton therapy for cranial and extracranial solitary fibrous tumors. BJR|Open, 8(1). https://doi.org/10.1093/bjro/tzag023
Vancouver
Reinhardt P, Bolsi A, Weber DC. Clinical outcomes and quality of life after proton therapy for cranial and extracranial solitary fibrous tumors. BJR|Open. 2026;8(1). doi:10.1093/bjro/tzag023
BibTeX
@article{Reinhardt2026,
author = {Reinhardt, Philipp and Bolsi, Alessandra and Weber, Damien Charles},
title = {Clinical outcomes and quality of life after proton therapy for cranial and extracranial solitary fibrous tumors},
journal = {BJR|Open},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/bjro/tzag023}
}
EUVIMED